171 related articles for article (PubMed ID: 27532663)
21. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
22. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
23. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
24. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
25. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
26. Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
Rodrigues M; Ait Rais K; Salviat F; Algret N; Simaga F; Barnhill R; Gardrat S; Servois V; Mariani P; Piperno-Neumann S; Roman-Roman S; Delattre O; Cassoux N; Savignoni A; Stern MH; Pierron G
JAMA Ophthalmol; 2020 Feb; 138(2):182-188. PubMed ID: 31895446
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
28. Detection of M2-macrophages in uveal melanoma and relation with survival.
Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
[TBL] [Abstract][Full Text] [Related]
29. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of uveal melanoma.
Couturier J; Saule S
Dev Ophthalmol; 2012; 49():150-165. PubMed ID: 22042019
[TBL] [Abstract][Full Text] [Related]
31. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
32. SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.
Mori T; Sukeda A; Sekine S; Shibata S; Ryo E; Okano H; Suzuki S; Hiraoka N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5445-5451. PubMed ID: 29059311
[TBL] [Abstract][Full Text] [Related]
33. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
[TBL] [Abstract][Full Text] [Related]
35. Repression of genes involved in melanocyte differentiation in uveal melanoma.
Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
[TBL] [Abstract][Full Text] [Related]
36. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
37. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
[TBL] [Abstract][Full Text] [Related]
38. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
39. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
